Nationaler Qualitätskongress Gesundheit
mit Livestreams
Prof. Dr. Christof von Kalle
© Simone Baar

Prof. Dr. Christof von Kalle

BIH-Chair für Klinisch-Translationale Wissenschaften und Gründungsdirektor des vereinten Clinical Study Center von BIH und der Charité – Universitätsmedizin Berlin

Since Juni 2019 BIH Chair for Clinical Translational Sciences Founding Director of the joint Charité and BIH Clinical Study Center (CSC)

02/2019 – 02/2023 Member of the Advisory Council on the Assessment of Developments in the Health Care Sector (Federal Ministry of Health, BMG), Germany

04/2018 – 07/2019 Chief Research Officer (CRO), Sidra Institute, Doha, Katar

2005 – 05/2019 Head of the Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany

2005 – 03/2018 Director, National Center for Tumor Diseases (NCT) Heidelberg, Germany

2005 – 2008 Adjunct Professor of Pediatrics, Cincinnati Children’s Hospital Medical Center, Division of Experimental Hematology, Cincinnati, USA

2002 – 2005 Associate Professor, Pediatrics, program leader “Gene and Molecular Therapy”, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

2004 – 2005 Tenured Associate Professor, Internal Medicine, Freiburg University, Germany

2000 – 2005 Group Leader, Section of Hematopoiesis and Gene Transfer, Institute for Molecular Medicine, Freiburg University, Germany

1996 – 2005 Senior Clinical Investigator, Gene Therapy Program, and Senior Medical Staff Fellow Department of Internal Medicine, Freiburg University Medical School, Germany

1992 – 1994 Associate in Clinical Research, Fred Hutchinson Cancer Res. Center (FHCRC), Seattle, USA

1991 Medical PhD Degree (Doctor medicinae)